Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Rnf125em1flox/Cya
Common Name:
Rnf125-flox
Product ID:
S-CKO-13807
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rnf125-flox
Strain ID
CKOCMP-67664-Rnf125-B6N-VA
Gene Name
Rnf125
Product ID
S-CKO-13807
Gene Alias
4930553F04Rik; C730049O14Rik
Background
C57BL/6NCya
NCBI ID
67664
Modification
Conditional knockout
Chromosome
18
Phenotype
MGI:1914914
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Rnf125em1flox/Cya mice (Catalog S-CKO-13807) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000050004
NCBI RefSeq
NM_026301
Target Region
Exon 3
Size of Effective Region
~0.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Rnf125, also known as Ring Finger Protein 125, is an E3 ubiquitin ligase. Ubiquitin ligases play crucial roles in regulating protein degradation, which in turn impacts various biological pathways and processes. Rnf125 is involved in multiple pathways such as the SRSF1-ERK, Wnt/β-catenin, and antiviral innate immune response pathways, highlighting its importance in cell growth, inflammation, and immune regulation [1,3,4]. Genetic models, especially gene knockout (KO) and conditional knockout (CKO) mouse models, can be valuable for studying its functions in vivo.

In hepatocellular carcinoma (HCC), Rnf125 was found to be downregulated in tumour tissues, and its overexpression inhibited HCC proliferation and metastasis both in vitro and in vivo. Mechanistically, it interacts with SRSF1 and accelerates its proteasome-mediated degradation, impeding HCC progression by inhibiting the ERK signalling pathway [1].

In the context of endotoxemia, Rnf125 is an E3 ubiquitin ligase that initiates K63-linked ubiquitination of the NLRP3 leucine-rich repeat domain, and together with Cbl-b, sequentially ubiquitinates NLRP3, limiting inflammasome activation and endotoxemia [2].

In osteoarthritis (OA), adenovirus-mediated overexpression of Rnf125 inhibited the degradation of the extracellular matrix of chondrocytes induced by IL-1β. NFATC2 binds to the Rnf125 promoter and directly regulates its transcription, and Rnf125 leads to the ubiquitination and degradation of TRIM14, suppressing the Wnt/β-catenin signalling pathway [3].

In the antiviral innate immune response, CD97 upregulates Rnf125 expression to induce Rnf125-mediated RIG-I degradation via K48-linked ubiquitination, inhibiting virus-induced type-I interferon release and enhancing RNA virus replication [4].

In HCC, Rnf125-mediated ubiquitination of MCM6 regulates the proliferation of human liver HCC cells [5].

In cancer immunotherapy-related studies, Rnf125 interacts with PD-L1, promotes its K48-linked polyubiquitination and degradation, and in tumour-bearing mice, Rnf125 knockout led to higher PD-L1 levels and faster tumour growth, while overexpression had the opposite effect [6].

In asthma, Rnf125 was downregulated in the bronchial epithelium, and its hypermethylation promoted autophagy-induced oxidative stress by increasing HMGB1 stability [7].

Rnf125 also physically interacts with p53, ubiquitinates it, and targets it for proteasome degradation, negatively regulating p53 functions [8].

In head and neck squamous cell carcinoma (HNSCC), Rnf125 overexpression inhibited immune escape by promoting PD-L1 ubiquitinational degradation [9].

In conclusion, Rnf125 is a key E3 ubiquitin ligase involved in diverse biological processes. Model-based research, especially through KO/CKO mouse models, has revealed its significance in diseases like HCC, endotoxemia, OA, antiviral immune response, asthma, and cancers related to immune escape. Understanding Rnf125's functions provides potential therapeutic targets for these diseases.

References:
1. Feng, Zhigang, Ke, Shanjia, Wang, Chaoqun, Wu, Yaohua, Ma, Yong. 2023. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. In Oncogene, 42, 2017-2030. doi:10.1038/s41388-023-02710-w. https://pubmed.ncbi.nlm.nih.gov/37142680/
2. Tang, Juan, Tu, Sha, Lin, Guoxin, Lipkowitz, Stanley, Zhang, Jian. . Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia. In The Journal of experimental medicine, 217, . doi:10.1084/jem.20182091. https://pubmed.ncbi.nlm.nih.gov/31999304/
3. Lv, Runxiao, Du, Lili, Bai, Lunhao. 2023. RNF125, transcriptionally regulated by NFATC2, alleviates osteoarthritis via inhibiting the Wnt/β-catenin signaling pathway through degrading TRIM14. In International immunopharmacology, 125, 111191. doi:10.1016/j.intimp.2023.111191. https://pubmed.ncbi.nlm.nih.gov/37951197/
4. Chang, Huasong, Hou, Peili, Wang, Xuefeng, Gao, Yuwei, He, Hongbin. 2023. CD97 negatively regulates the innate immune response against RNA viruses by promoting RNF125-mediated RIG-I degradation. In Cellular & molecular immunology, 20, 1457-1471. doi:10.1038/s41423-023-01103-z. https://pubmed.ncbi.nlm.nih.gov/37978243/
5. Feng, Xueyi, Song, Dongqiang, Liu, Xiaolan, Wu, Shenwei, Liu, Fubao. 2024. RNF125‑mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells. In Oncology letters, 27, 105. doi:10.3892/ol.2024.14238. https://pubmed.ncbi.nlm.nih.gov/38298426/
6. Wei, Meng, Mo, Yunhai, Liu, Jialong, Min, Min, Wu, Feixiang. 2022. Ubiquitin ligase RNF125 targets PD-L1 for ubiquitination and degradation. In Frontiers in oncology, 12, 835603. doi:10.3389/fonc.2022.835603. https://pubmed.ncbi.nlm.nih.gov/35965501/
7. Hu, Jiapeng, Ding, Ruiwei, Liu, Shaozhuang, Li, Jianjun, Shang, Yunxiao. 2023. Hypermethylation of RNF125 promotes autophagy-induced oxidative stress in asthma by increasing HMGB1 stability. In iScience, 26, 107503. doi:10.1016/j.isci.2023.107503. https://pubmed.ncbi.nlm.nih.gov/37599832/
8. Yang, Liuzhong, Zhou, Bing, Li, Xiaorui, Huo, Xiaoqing, Miao, Zhanhui. 2015. RNF125 is a ubiquitin-protein ligase that promotes p53 degradation. In Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 35, 237-45. doi:10.1159/000369691. https://pubmed.ncbi.nlm.nih.gov/25591766/
9. Jiang, Cuihong, He, Lili, Xiao, Shuai, Zhao, Qi, Liu, Feng. 2022. E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression. In Molecular biotechnology, 65, 891-903. doi:10.1007/s12033-022-00587-w. https://pubmed.ncbi.nlm.nih.gov/36344734/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest